Literature DB >> 30355487

Active Ribosome Profiling with RiboLace.

Massimiliano Clamer1, Toma Tebaldi2, Fabio Lauria3, Paola Bernabò3, Rodolfo F Gómez-Biagi4, Marta Marchioretto3, Divya T Kandala5, Luca Minati5, Elena Perenthaler3, Daniele Gubert6, Laura Pasquardini4, Graziano Guella7, Ewout J N Groen8, Thomas H Gillingwater8, Alessandro Quattrone2, Gabriella Viero9.   

Abstract

Ribosome profiling, or Ribo-seq, is based on large-scale sequencing of RNA fragments protected from nuclease digestion by ribosomes. Thanks to its unique ability to provide positional information about ribosomes flowing along transcripts, this method can be used to shed light on mechanistic aspects of translation. However, current Ribo-seq approaches lack the ability to distinguish between fragments protected by either ribosomes in active translation or inactive ribosomes. To overcome this possible limitation, we developed RiboLace, a method based on an original puromycin-containing molecule capable of isolating active ribosomes by means of an antibody-free and tag-free pull-down approach. RiboLace is fast, works reliably with low amounts of input material, and can be easily and rapidly applied both in vitro and in vivo, thereby generating a global snapshot of active ribosome footprints at single nucleotide resolution.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  polysomal profiling; protein synthesis; proteome; puromycin; ribosome; ribosome profiling; translation; translational control; translatome

Mesh:

Substances:

Year:  2018        PMID: 30355487     DOI: 10.1016/j.celrep.2018.09.084

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  17 in total

1.  Phospho-RNA sequencing with circAID-p-seq.

Authors:  Alessia Del Piano; Tea Kecman; Michael Schmid; Ruggero Barbieri; Luciano Brocchieri; Silvia Tornaletti; Claudia Firrito; Luca Minati; Paola Bernabo; Ilaria Signoria; Fabio Lauria; Thomas H Gillingwater; Gabriella Viero; Massimiliano Clamer
Journal:  Nucleic Acids Res       Date:  2022-02-28       Impact factor: 16.971

2.  Large protein complex interfaces have evolved to promote cotranslational assembly.

Authors:  Mihaly Badonyi; Joseph A Marsh
Journal:  Elife       Date:  2022-07-28       Impact factor: 8.713

3.  Deciphering the immunopeptidome in vivo reveals new tumour antigens.

Authors:  Alex M Jaeger; Lauren E Stopfer; Ryuhjin Ahn; Emma A Sanders; Demi A Sandel; William A Freed-Pastor; William M Rideout; Santiago Naranjo; Tim Fessenden; Kim B Nguyen; Peter S Winter; Ryan E Kohn; Peter M K Westcott; Jason M Schenkel; Sean-Luc Shanahan; Alex K Shalek; Stefani Spranger; Forest M White; Tyler Jacks
Journal:  Nature       Date:  2022-06-15       Impact factor: 69.504

Review 4.  Advancements in Genomic and Behavioral Neuroscience Analysis for the Study of Normal and Pathological Brain Function.

Authors:  Annalisa M Baratta; Adam J Brandner; Sonja L Plasil; Rachel C Rice; Sean P Farris
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

5.  Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome.

Authors:  Mirko Luoni; Serena Giannelli; Marzia Tina Indrigo; Antonio Niro; Luca Massimino; Angelo Iannielli; Laura Passeri; Fabio Russo; Giuseppe Morabito; Piera Calamita; Silvia Gregori; Benjamin Deverman; Vania Broccoli
Journal:  Elife       Date:  2020-03-24       Impact factor: 8.140

6.  Robust single-cell discovery of RNA targets of RNA-binding proteins and ribosomes.

Authors:  Kristopher W Brannan; Isaac A Chaim; Ryan J Marina; Brian A Yee; Eric R Kofman; Daniel A Lorenz; Pratibha Jagannatha; Kevin D Dong; Assael A Madrigal; Jason G Underwood; Gene W Yeo
Journal:  Nat Methods       Date:  2021-05-07       Impact factor: 47.990

Review 7.  Translational control in aging and neurodegeneration.

Authors:  Geena Skariah; Peter K Todd
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-09-20       Impact factor: 9.349

8.  Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.

Authors:  Christopher P Mill; Warren Fiskus; Courtney D DiNardo; Christine Birdwell; John A Davis; Tapan M Kadia; Koichi Takahashi; Nicholas Short; Naval Daver; Maro Ohanian; Gautam Borthakur; Steven M Kornblau; Michael R Green; Yuan Qi; Xiaoping Su; Joseph D Khoury; Kapil N Bhalla
Journal:  Blood       Date:  2022-02-10       Impact factor: 25.476

Review 9.  The science of puromycin: From studies of ribosome function to applications in biotechnology.

Authors:  Ranen Aviner
Journal:  Comput Struct Biotechnol J       Date:  2020-04-24       Impact factor: 7.271

10.  Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.

Authors:  Ali Bayoumi; Asmaa Elsayed; Shuanglin Han; Salvatore Petta; Leon A Adams; Rocio Aller; Anis Khan; Carmelo García-Monzón; María Teresa Arias-Loste; Luca Miele; Olivier Latchoumanin; Shafi Alenizi; Rocio Gallego-Durán; Janett Fischer; Thomas Berg; Antonio Craxì; Mayada Metwally; Liang Qiao; Christopher Liddle; Hannele Yki-Järvinen; Elisabetta Bugianesi; Manuel Romero-Gomez; Jacob George; Mohammed Eslam
Journal:  Adv Sci (Weinh)       Date:  2021-05-01       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.